Caudate glucose hypometabolism in a subject carrying an unstable allele of intermediate CAG33 repeat length in the Huntington's disease gene

2011 ◽  
Vol 26 (5) ◽  
pp. 925-927 ◽  
Author(s):  
Ferdinando Squitieri ◽  
Mouna Esmaeilzadeh ◽  
Andrea Ciarmiello ◽  
Joseph Jankovic
Neurology ◽  
1994 ◽  
Vol 44 (11) ◽  
pp. 2183-2183 ◽  
Author(s):  
H. Shinotoh ◽  
D. B. Calne ◽  
B. Snow ◽  
M. Hayward ◽  
B. Kremer ◽  
...  

1991 ◽  
Vol 28 (8) ◽  
pp. 520-522 ◽  
Author(s):  
L Barron ◽  
A Curtis ◽  
A E Shrimpton ◽  
S Holloway ◽  
H May ◽  
...  

2016 ◽  
Vol 368 ◽  
pp. 243-248 ◽  
Author(s):  
Heather Wilson ◽  
Flavia Niccolini ◽  
Salman Haider ◽  
Tiago Reis Marques ◽  
Gennaro Pagano ◽  
...  

2007 ◽  
Vol 19 (4) ◽  
pp. 441-448 ◽  
Author(s):  
E. van Duijn ◽  
E.M. Kingma ◽  
R.C. van der Mast

2020 ◽  
Vol 10 (9) ◽  
pp. 575 ◽  
Author(s):  
Jordan L. Schultz ◽  
Amelia D. Moser ◽  
Peg C. Nopoulos

There is a known negative association between cytosine–adenine–guanine (CAG) repeat length and the age of motor onset (AMO) in adult-onset Huntington’s Disease (AOHD). This relationship is less clear in patients with juvenile-onset Huntington’s disease (JOHD), however, given the rarity of this patient population. The aim of this study was to investigate this relationship amongst a relatively large group of patients with JOHD using data from the Kids-JOHD study. Additionally, we analyzed data from the Enroll-HD platform and the Predict-HD study to compare the relationship between CAG repeat length and AMO amongst patients with AOHD to that amongst patients with JOHD using linear regression models. In line with previous reports, the variance in AMO that was predicted by CAG repeat length was 59% (p < 0.0001) in the Predict-HD study and 57% from the Enroll-HD platform (p < 0.0001). However, CAG repeat length predicted 84% of the variance in AMO amongst participants from the Kids-JOHD study (p < 0.0001). These results indicate that there may be a stronger relationship between CAG repeat length and AMO in patients with JOHD as compared to patients with AOHD. These results provide additional information that may help to model disease progression of JOHD, which is beneficial for the planning and implementation of future clinical trials.


1994 ◽  
Vol 3 (1) ◽  
pp. 73-78 ◽  
Author(s):  
H. Hummerich ◽  
S. Baxendale ◽  
R. Mott ◽  
S. F.Kirby ◽  
M. E.MacDonald ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document